149 related articles for article (PubMed ID: 11758141)
1. Fatal cardiac malformation in fetal valproate syndrome.
Sodhi P; Poddar B; Parmar V
Indian J Pediatr; 2001 Oct; 68(10):989-90. PubMed ID: 11758141
[TBL] [Abstract][Full Text] [Related]
2. Congenital abnormalities and anticonvulsant drugs.
Meadow SR
Proc R Soc Med; 1970 Jan; 63(1):48-9. PubMed ID: 5417773
[No Abstract] [Full Text] [Related]
3. [Fetal valproate syndrome].
Taubøll E; Gjerstad L; Henriksen T; Husby H
Tidsskr Nor Laegeforen; 2003 Oct; 123(19):2765. PubMed ID: 14600761
[No Abstract] [Full Text] [Related]
4. Fetal valproate syndrome.
Clayton-Smith J; Donnai D
J Med Genet; 1995 Sep; 32(9):724-7. PubMed ID: 8544193
[No Abstract] [Full Text] [Related]
5. Complex cardiac defect with hypoplastic right ventricle in a fetus with valproate exposure.
ten Berg K; van Oppen AC; Nikkels PG; Gittenberger-de Groot AC; van der Voet GB; Brilstra EH; Lindhout D
Prenat Diagn; 2005 Feb; 25(2):156-8. PubMed ID: 15712340
[TBL] [Abstract][Full Text] [Related]
6. Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy.
Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
J Neurol; 2014 Mar; 261(3):579-88. PubMed ID: 24449062
[TBL] [Abstract][Full Text] [Related]
7. Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.
Thisted E; Ebbesen F
Arch Dis Child; 1993 Sep; 69(3 Spec No):288-91. PubMed ID: 8215567
[TBL] [Abstract][Full Text] [Related]
8. Maternal epilepsy and birth defects: a case-control study in the Italian Multicentric Registry of Birth Defects (IPIMC).
Bertollini R; Mastroiacovo P; Segni G
Eur J Epidemiol; 1985 Mar; 1(1):67-72. PubMed ID: 3939491
[TBL] [Abstract][Full Text] [Related]
9. Dangers of valproate in pregnancy.
Wieck A; Jones S
BMJ; 2018 Apr; 361():k1609. PubMed ID: 29669728
[No Abstract] [Full Text] [Related]
10. Fetal Valproate Syndrome - Still a Problem Today!
Wiedemann K; Stüber T; Rehn M; Frieauff E
Z Geburtshilfe Neonatol; 2017 Oct; 221(5):243-246. PubMed ID: 29073690
[No Abstract] [Full Text] [Related]
11. [The first case of a child born with fetal valproic acid syndrome in Hungary].
Robinek F; Czeizel E
Orv Hetil; 1989 Jan; 130(5):267. PubMed ID: 2492655
[No Abstract] [Full Text] [Related]
12. Women still not being told about pregnancy risks of valproate.
Wise J
BMJ; 2017 Sep; 358():j4426. PubMed ID: 28939551
[No Abstract] [Full Text] [Related]
13. Pregnancy, epilepsy, management and outcome: a 10-year perspective.
Martin PJ; Millac PA
Seizure; 1993 Dec; 2(4):277-80. PubMed ID: 8162395
[TBL] [Abstract][Full Text] [Related]
14. Unilateral lung agenesis: coincidence or association with maternal valproate therapy?
Trivedi A; Halliday R; Waters K; Levison J
J Paediatr Child Health; 2009 Oct; 45(10):622-3. PubMed ID: 19825029
[No Abstract] [Full Text] [Related]
15. Atrioventricular septal defect with separate right and left atrioventricular valvar orifices in a patient with foetal hydantoin syndrome.
Grech V; Vella C
Cardiol Young; 1999 Jan; 9(1):73-4. PubMed ID: 10323545
[TBL] [Abstract][Full Text] [Related]
16. Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.
Hockey A; Bower C; Goldblatt J; Knowles S
Birth Defects Orig Artic Ser; 1996; 30(1):401-5. PubMed ID: 9125345
[No Abstract] [Full Text] [Related]
17. Teratogenicity of antiepileptic drugs.
Starreveld-Zimmerman AA; van der Kolk WJ; Elshove J; Meinardi H
Clin Neurol Neurosurg; 1975 Dec; 77(2):81-95. PubMed ID: 1132213
[No Abstract] [Full Text] [Related]
18. In-utero exposure to valproate and neural tube defects.
Lindhout D; Schmidt D
Lancet; 1986 Jun; 1(8494):1392-3. PubMed ID: 2872511
[No Abstract] [Full Text] [Related]
19. [Fetal valproate syndrome].
Houge G; Fiskerstrand T; Øyen N
Tidsskr Nor Laegeforen; 2003 Aug; 123(16):2331. PubMed ID: 14508573
[No Abstract] [Full Text] [Related]
20. France steps up warning measures for valproate drugs.
Casassus B
Lancet; 2016 Mar; 387(10024):1148. PubMed ID: 27025323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
